Home » Headlines » Currently Reading:

Morning Headlines 4/24/15

April 23, 2015 Headlines 2 Comments

U.S. cancer institute, software firm reach deals in Cuba

Two New York-based healthcare companies are among the first to sign commercial agreements in Cuba. The Roswell Park Cancer Institute of Buffalo, New York will work on lung cancer vaccinations with Cuba’s Center for Molecular Immunology, and Infor has found a partner that will resell its integration engine software in Cuba.

Few People Lost Jobs With V.A. in Scandal

A New York Times investigation finds that only three VA employees lost their jobs over the VA wait-time scandal, far less than the 60 people that VA Secretary Robert McDonald reported during a NBC television interview he did in February. Additionally, only eight of the VA’s 280,000 other employees were punished in some way for their involvement in the scandal.

WebMD Deserves Fees In Failed Patent Case, Judge Says

MMRGlobal, which sued both WebMD and Allscripts over frivolous patent infringements claims, has lost both claims and will now have to pay each company’s legal fees.

Oxycodone overdose deaths drop 25 percent after launch of Florida’s Prescription Drug Monitoring Program

Oxycodone-related deaths dropped 25 percent after Florida implemented a controlled prescriptions database. However, the project went live in tandem with state-wide efforts to shut down prescription mills posing as pain clinics, which likely also contributed to the reduced deaths.

View/Print Text Only View/Print Text Only

HIStalk Featured Sponsors


Currently there are "2 comments" on this Article:

  1. Oxycodone deaths may have dropped but the heroin deaths probably tripled. Most addicts are moving away from narcotics, not because of some implemented check system, but because of its availability and being inexpensive. Might want to consider that before patting themselves on their backs about a program that has nothing to do with the real reason why it is less.

  2. I wanted to clarify my above comment. As a front physician that sees the patterns of addiction. I can tell you that oxycodone is much less popular because heroin, meth, spice (synth marijuana) is much MORE popular, most due to availability and costs. Again be wary of all the self congratulatory studies that show that some monitoring program is the reason for the reduction in prescription overdosing. We monitor EVERY patient that receives narcotics and it is VERY few that actually try to abuse the system. I’m not saying its unimportant, but I don’t think its the reason for less oxycodone related OD.

Subscribe to Updates



Text Ads

Report News and Rumors

No title

Anonymous online form
Rumor line: 801.HIT.NEWS



Founding Sponsors


Platinum Sponsors































































Gold Sponsors















Reader Comments

  • richie: Wonderful topic (I'm biased as I strive to implement systems I'd want, prior to my own long-term care becoming imminent)...
  • richie: Thanks Ed, I'm impressed by your ability to pursue new endeavors....
  • Melissa: I have enjoyed your posts every month, and have followed you through your life changes as well as mine. Thank you for a...
  • Edward Marx: That would make for a good post! Let me think on it and look for me on LinkedIn....
  • Rebecca: Thank you, Ed. I always looked forward to your posts - they were a validation to me that you don't have to have to be a...
  • Lee David Milligan: Rob: thanks for the comment. Agree with your point re: unique expectations and complexity....
  • Shelly: Thank you Ed for taking the time to invest in the industry as you have done - with this blog as a sounding board for CIO...
  • Appreciatve: Thanks,, Ed. This was a very nice piece, and telling of what you cherish most. There is one topic that I am not cert...
  • Rob Price: Excellent information and quite consistent with my experiences since 1999 working with three different software companie...
  • Cosmos: Thank you for the interesting article. FYI - the terms "Severe Sepsis" and "Septicemia" are no longer in common use, ...

Sponsor Quick Links